Kunming Longjin Pharmaceutical Co., Ltd.
SZSE:002750.SZ
9.92 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 210.737 | 191.072 | 102.039 | 123.977 | 195.429 | 384.284 | 70.887 | 55.42 | 199.257 | 92.417 | 87.03 | 95.194 | 63.619 |
| Short Term Investments
| 123.412 | 213.275 | 327.453 | 287.61 | 208.303 | -1.975 | -3.112 | -1.795 | 170 | 0 | 0 | 0 | -0.091 |
| Cash and Short Term Investments
| 334.149 | 404.347 | 429.491 | 411.587 | 403.731 | 384.284 | 70.887 | 55.42 | 199.257 | 92.417 | 87.03 | 95.194 | 63.619 |
| Net Receivables
| 12.519 | 19.779 | 36.986 | 44.911 | 33.977 | 37.573 | 0 | 0 | 175.591 | 2.905 | 3.795 | 4.279 | 15.079 |
| Inventory
| 28.65 | 27.779 | 32.905 | 54.671 | 35.716 | 27.185 | 29.87 | 23.051 | 18.239 | 16.189 | 12.042 | 10.45 | 7.365 |
| Other Current Assets
| 8.739 | 19.131 | 23.385 | 8.441 | 6.059 | 23.528 | 325.463 | 16.138 | 23.5 | 24.988 | 19.624 | 12.781 | 21.791 |
| Total Current Assets
| 384.056 | 471.036 | 522.767 | 519.611 | 479.482 | 472.57 | 478.672 | 449.762 | 416.588 | 136.499 | 122.491 | 122.704 | 107.855 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 178.269 | 202.478 | 223.254 | 239.526 | 242.359 | 230.521 | 245.653 | 247.657 | 261.607 | 279.079 | 299.181 | 217.687 | 139.83 |
| Goodwill
| 2.643 | 0 | 1.897 | 2.053 | 2.053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 56.806 | 44.994 | 47.183 | 46.701 | 50.118 | 31.025 | 18.381 | 18.897 | 19.414 | 19.847 | 20.359 | 20.872 | 21.384 |
| Goodwill and Intangible Assets
| 59.449 | 44.994 | 49.079 | 48.753 | 52.171 | 31.025 | 18.381 | 18.897 | 19.414 | 19.847 | 20.359 | 20.872 | 21.384 |
| Long Term Investments
| 0.42 | -206.275 | -308.653 | -266.91 | -186.403 | 25.675 | 30.412 | 33.148 | 0 | -299.089 | 0 | 0 | 8.854 |
| Tax Assets
| 1.616 | 3.18 | 7.873 | 7.304 | 6.874 | 8.44 | 10.017 | 1.884 | 0.321 | 0.163 | 0.346 | 0.42 | 0.369 |
| Other Non-Current Assets
| 7.824 | 231.792 | 332.96 | 293.472 | 212.409 | 19.319 | 2.094 | 8.331 | 0.929 | 299.089 | 0.186 | 6.371 | 9.073 |
| Total Non-Current Assets
| 247.578 | 276.169 | 304.513 | 322.145 | 327.41 | 314.98 | 306.557 | 309.918 | 282.271 | 299.089 | 320.072 | 245.35 | 179.51 |
| Total Assets
| 631.634 | 747.205 | 827.28 | 841.756 | 806.892 | 787.55 | 785.229 | 759.68 | 698.859 | 435.588 | 442.563 | 368.054 | 287.365 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 9.294 | 10.103 | 11.825 | 15.277 | 13.99 | 14.982 | 6.782 | 5.815 | 8.7 | 25.582 | 44.14 | 16.976 | 14.91 |
| Short Term Debt
| 0 | 0 | 0 | 0.156 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | 0 | 20 |
| Tax Payables
| 2.342 | 10.348 | 8.128 | 2.709 | 5.032 | 6.142 | 16.389 | 11.001 | 8.244 | 5.347 | 8.579 | 6.537 | 8.028 |
| Deferred Revenue
| 0.789 | 1.632 | 100.886 | 2.329 | 2.323 | 2.527 | 1.417 | 8.735 | 0 | 24.31 | 0 | 0 | 20.275 |
| Other Current Liabilities
| 37.715 | 65.574 | -7.442 | 79.812 | 86.23 | 78.311 | 88.714 | 44.718 | 53.107 | 64.148 | 66.333 | 105.617 | 47.185 |
| Total Current Liabilities
| 50.139 | 87.657 | 113.396 | 100.284 | 105.251 | 99.435 | 111.886 | 61.534 | 70.051 | 125.077 | 119.052 | 129.13 | 90.124 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 0.804 | 0.984 | 1.155 | 1.319 | 0 | 0 | 0 | 0.266 | 0.355 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 39.492 | 41.501 | 34.434 | 36.657 | 35.561 | 32.182 | 27.803 | 27.424 | 29.045 | 24.498 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.073 | 0 | -34.434 | 0.109 | 0.191 | 0 | 0 | -0.266 | -0.355 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 53.799 | 0 | 36.657 | 0 | 0 | 0 | 27.424 | 29.045 | 0.443 | 21.514 | 11.983 | 10.5 |
| Total Non-Current Liabilities
| 40.369 | 54.783 | 35.589 | 36.766 | 35.752 | 32.182 | 27.803 | 27.69 | 29.4 | 24.941 | 21.514 | 11.983 | 10.5 |
| Total Liabilities
| 90.508 | 142.44 | 148.986 | 137.05 | 141.003 | 131.617 | 139.689 | 89.224 | 99.451 | 150.018 | 140.566 | 141.113 | 100.624 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 400.5 | 400.5 | 400.5 | 400.5 | 400.5 | 400.5 | 400.5 | 400.5 | 200.25 | 50 | 50 | 50 | 50 |
| Retained Earnings
| 60.394 | 131.336 | 187.452 | 185.88 | 176.255 | 199.404 | 198.943 | 227.415 | 207.383 | 202.143 | 218.57 | 143.514 | 109.338 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 51.082 | 51.082 | 49.561 | 47.374 | 47.374 | 45.985 | 42.428 | 35.505 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 50.993 | 0.113 | 0.113 | 0.113 | 0.113 | 47.491 | 0.113 | 0.113 | 156.308 | 33.427 | 33.427 | 33.427 | 27.403 |
| Total Shareholders Equity
| 511.887 | 583.031 | 639.147 | 636.054 | 624.242 | 647.395 | 645.54 | 670.456 | 599.446 | 285.57 | 301.997 | 226.941 | 186.741 |
| Total Equity
| 541.126 | 604.766 | 678.294 | 704.706 | 665.889 | 655.933 | 645.54 | 670.456 | 599.408 | 285.57 | 301.997 | 226.941 | 186.741 |
| Total Liabilities & Shareholders Equity
| 631.634 | 747.205 | 827.28 | 841.756 | 806.892 | 787.55 | 785.229 | 759.68 | 698.859 | 435.588 | 442.563 | 368.054 | 287.365 |